Clinical research - Press Releases

Date	Title	Company
05-Apr-2021	Risk Invovled In Clinical Trial for Clinical Research	Clariwell Global Services LLP
01-Apr-2021	Medical Perfusion Technology Market by Technology Trends 2021 - XVIVO Perfusion, OrganOx Limited, TransMedics, Organ Recovery Systems, Xenios AG	theinsightpartners
01-Apr-2021	Microplate Reader Market Outlook and Business Opportunities 2020-2027 - BMG Labtech, Hercuvan Lab Systems, Molecular Devices	theinsightpartners
31-Mar-2021	Seegnal’s Drug Interaction Prevention Platform 20-fold More Accurate than Standard Tech	Seegnal
31-Mar-2021	Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site	Panthera Biopartners
31-Mar-2021	Global Oncology Biosimilar Treatment Market is estimated to be US$ 44439.4 million by 2030 with a CAGR of 57.6% during the forecast period	Prophecy Market Insights
31-Mar-2021	Medigene AG: Publication of research on co-receptor independent MAGE-A4-specific T cell receptor	Medigene AG
30-Mar-2021	Reltio Launches Enterprise 360 Site Intelligence to Accelerate Clinical Trials	Reltio
30-Mar-2021	NERVE MATTERS: SCIENTIFIC STUDY IDENTIFIES ION CHANNEL COMPONENTS AS CRITICAL REGULATORS OF NEURONAL CONNECTIONS	the Karl Landsteiner University of Health Sciences
29-Mar-2021	EMA issues advice on the use of Celltrion’s anti-COVID-19 monoclonal antibody treatment regdanvimab (CT-P59) for COVID-19 patients in the European Union	Celltrion Group
29-Mar-2021	OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer	OKYO Pharma Limited
29-Mar-2021	Instant Covid Tests London to launch first test centre using 20-second Virolens technology	Instant Covid Tests London (ICTL)
29-Mar-2021	Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation	Vertex Pharmaceuticals Incorporated
29-Mar-2021	Gadopiclenol: positive results for Phase III clinical trials	Guerbet
29-Mar-2021	Avifavir obtains its first registration in Asia	Russian Direct Investment Fund
29-Mar-2021	PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey	PrecisionLife
29-Mar-2021	LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology	Nordic Capital
29-Mar-2021	Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials	Amzell BV
29-Mar-2021	Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support	Qlucore
29-Mar-2021	Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases	Augustine Therapeutics